Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. The company is headquartered in Melville, New York. The company went IPO on 2022-04-14. The firm is engaged in offering patented smart-safety syringe products to the healthcare industry. The firm's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. The company Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. The company also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The company has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
Quelle est la performance du prix de l'action STSS ?
Le prix actuel de STSS est de $1.99, il a diminué de 0.5% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Sharps Technology Inc ?
Sharps Technology Inc appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Sharps Technology Inc ?
La capitalisation boursière actuelle de Sharps Technology Inc est de $76.9M
Est-ce que Sharps Technology Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 3 analystes ont établi des notations d'analystes pour Sharps Technology Inc, y compris 2 achat fort, 4 achat, 1 maintien, 0 vente et 2 vente forte
